KERYX BIOPHARMACEUTICALS INC·4

Jan 31, 5:19 PM ET

Madison Greg 4

4 · KERYX BIOPHARMACEUTICALS INC · Filed Jan 31, 2018

Insider Transaction Report

Form 4
Period: 2017-11-07
Madison Greg
See Remarks
Transactions
  • Award

    Common Stock

    2017-11-07+125,000492,620 total
  • Award

    Common Stock

    2018-01-29$4.81/sh4,403$21,178429,404 total
  • Tax Payment

    Common Stock

    2017-11-07$5.15/sh58,813$302,887433,807 total
Footnotes (4)
  • [F1]The 125,000 shares are shares of common stock that were delivered to the reporting person upon the achievement of a performance condition associated with a portion of a restricted stock award that was granted on April 30, 2015.
  • [F2]A total of 58,813 shares of common stock were surrendered by Mr. Madison and returned to the company in order to satisfy Mr. Madison's income tax withholding obligation upon the vesting of the 125,000 shares of restricted stock on November 6, 2017.
  • [F3]Sale of a total of 4,403 shares of common stock was made in order to satisfy Mr. Madison's income tax withholding obligation upon the vesting of 12,812 shares of restricted stock on January 26, 2018. Mr. Madison had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
  • [F4]Includes 201,248 shares of restricted stock.

Documents

1 file
  • 4
    wf-form4_151743717042843.xmlPrimary

    FORM 4